Bain Capital Life Sciences Investors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,080,237
| Closed | -$62.1M | – | 36 |
|
|
2021
Q3 | $62.1M | Hold |
3,080,237
| – | – | 3.85% | 9 |
|
|
2021
Q2 | $115M | Hold |
3,080,237
| – | – | 7.53% | 4 |
|
|
2021
Q1 | $78.8M | Hold |
3,080,237
| – | – | 4.46% | 7 |
|
|
2020
Q4 | $67.9M | Sell |
3,080,237
-1,000,000
| -25% | -$22M | 4.26% | 6 |
|
|
2020
Q3 | $73.4M | Hold |
4,080,237
| – | – | 6.84% | 4 |
|
|
2020
Q2 | $104M | Hold |
4,080,237
| – | – | 10.85% | 3 |
|
|
2020
Q1 | $75M | Hold |
4,080,237
| – | – | 12.68% | 3 |
|
|
2019
Q4 | $89.9M | Sell |
4,080,237
-3,250,000
| -44% | -$71.6M | 13.41% | 3 |
|
|
2019
Q3 | $105M | Hold |
7,330,237
| – | – | 27.1% | 2 |
|
|
2019
Q2 | $115M | Sell |
7,330,237
-1,600,000
| -18% | -$25.2M | 58.64% | 1 |
|
|
2019
Q1 | $131M | Hold |
8,930,237
| – | – | 52.31% | 1 |
|
|
2018
Q4 | $95.5M | Hold |
8,930,237
| – | – | 32.62% | 1 |
|
|
2018
Q3 | $136M | Hold |
8,930,237
| – | – | 30.93% | 1 |
|
|
2018
Q2 | $109M | Hold |
8,930,237
| – | – | 34.28% | 1 |
|
|
2018
Q1 | $85.4M | Hold |
8,930,237
| – | – | 50.34% | 1 |
|
|
2017
Q4 | $80.6M | Buy |
+8,930,237
| New | +$80.6M | 52.91% | 1 |
|